It showed that the CSF Ng levels are significantly lower in mild-to-moderate PD than those in controls and associated with CSF Aβ levels, CSF α-synuclein levels, and motor stage (Selnes et al., 2017). This evidence concerns the gene NRGN and Parkinson disease.